Brimonidine-d4 L-Tartrate

CAS : 70359-46-5

Ref. TR-B677533

Informations sur le produit

• Nom: Brimonidine-d4 L-Tartrate
• Synonymes: 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl-4,4,5,5-d4)quinoxalin-6-amine (2R,3R)-2,3-dihydroxysuccinate, (5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine L-tartrate, 5-Bromo-N-(4,5-Dihydro-1H-Imidazol-2-Yl)-6-Quinoxalinamine Tartrate, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine 2,3-dihydroxybutanedioate (1:1), 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine 2,3-dihydroxybutanedioate (salt), 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1), 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1), Agn 190342Lf, Alphagan, Alphagan P, Brimonidine Purite, Brimonidine tartrate, Brominide tartrate, Mirvaso

Description

Applications Labelled Brimonidine. It is an α2 receptor agonist. It is a drug used to treat glaucoma.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Katz, L.J., et al.: Am. J. Ophthalmol., 127, 20 (1999), Cantor, L. B., Expert Opin. Pharmacother., 1, 815 (2000),

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 446.25
• Formule: C₁₁H₆D₄BrN₅·C₄H₆O₆
• Couleur/Forme: Neat
• InChI: InChI=1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1/i5D2,6D2
• Code InChI: InChIKey=QZHBYNSSDLTCRG-HDFODYMNSA-N
• SMILES: O=C(O)[C@H](O)[C@@H](O)C(=O)O.[2H]C1([2H])N=C(Nc2ccc3nccnc3c2Br)NC1([2H])[2H]